-
Components of the blood or hematopoietic system derive from stem cell subtypes rather than one single stem cell that gives rise to all the different kinds of blood cells equally, said scientists from Baylor College of Medicine in a report that appears in the current issue of the journal Cell Stem Cell .
Baylor College of Medicine (Ematologia) - Mar, 9 Marzo 2010
http://www.bcm.edu
-
NICE is unable to recommend the use of dasatinib and nilotinib for the treatment of chronic myeloid leukaemia in patients who cannot tolerate the first-line treatment imatinib, after finding that the evidence to support their use is "very poor".
National Institute for Health and Clinical Excellence (Ematologia) - Ven, 12 Febbraio 2010
http://www.nice.org.uk
-
Blood transfusion — Overview covers benefits, risks and what to expect.
MayoClinic.com (Ematologia) - Ven, 22 Gennaio 2010
http://www.mayoclinic.com
-
Anemia ranges in prevalence from below 10% among patients with mild heart failure symptoms to over 40% for patients with advanced disease.1 Its prevalence is similar among patients who have systolic dysfunction and among patients who have heart failure with preserved systolic function. Anemia has been associated with older age, diabetes mellitus, chronic renal dysfunction, more advanced heart failure symptoms, lower peak exercise capacity, and worse health-related quality-of-life metrics. Anemia has also been shown to be a powerful predictor of rehospitalization rates and survival in chronic heart failure.
New England Journal of Medicine (Ematologia) - Gio, 17 Dicembre 2009
http://www.nejm.org
-
Polyphosphate from blood platelets plays a key role in inflammation and the formation of blood clots, scientists from Karolinska Institutet have shown. The study, which is presented in the prestigious scientific journal Cell, describes how this mechanism can be used in treatment.
Karolinska Institutet (Ematologia) - Ven, 11 Dicembre 2009
http://ki.se/ki/jsp/polopoly.jsp?d=130&l=en
-
Scientific advances are producing potential new biomarkers that help predict response to cancer therapeutics, and thus individualize treatment and improve outcomes.
Medscape (Ematologia) - Mar, 24 Novembre 2009
http://www.medscape.com
-
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection, said a group of researchers led by those from Baylor College of Medicine , The Methodist Hospital and Texas Children's Hospital.
Baylor College of Medicine (Ematologia) - Ven, 6 Novembre 2009
http://www.bcm.edu
-
This review gives an account of the clinical and hematologic features of the myelodysplastic syndromes. It supplies the latest classification of these disorders, discusses the cytogenetic and molecular genetic changes that occur, and analyzes how some of these conditions convert to acute myeloid leukemia.
New England Journal of Medicine (Ematologia) - Ven, 6 Novembre 2009
http://www.nejm.org
-
Pemetrexed is the first maintenance therapy approved for advanced lung cancer; the pivotal trial is now published and a related editorial looks at treatment timing.
Medscape (Ematologia) - Ven, 30 Ottobre 2009
http://www.medscape.com
-
The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow.
Food and Drug Administration (Ematologia) - Ven, 30 Ottobre 2009
http://www.fda.gov